Drugdiscovery >> Clinical Trials >> News
6264
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial - drugdiscovery.com
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial - drugdiscovery.com


The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune cells.
Read More >>


Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine - September 10, 2013
Related Articles
2254
Views
MAGE-A3 immunotherapy fails to slow melanoma in Phase 3 trial MAGE-A3 immunotherapy fails to slow melanoma in Phase 3 trial
GlaxoSmithKline’s investigational melanoma vaccine failed to slow progression of advanced melanoma (the first of two co-primary endpoints) in a randomized, phase 3 clinical trial. Follow-up in the t Read More >>

Tags: MAGE-A3, immunotherapy, melanoma, vaccine, Glaxo, clinical trial

6948
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

2804
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

4963
Views
GSK’s  malaria vaccine candidate shows promise in Phase 3 trial GSK’s malaria vaccine candidate shows promise in Phase 3 trial
According to the results of a large-scale Phase 3 trial, the vaccine candidate RTS,S, showed efficient at protecting young children and infants from clinical malaria up to 18 months after vaccination. Read More >>

Tags: GSK, malaria vaccine, malaria, RTS,S, clinical trial

4561
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

7923
Views
Glioblastoma multiforme vaccine successful in Phase 2 Glioblastoma multiforme vaccine successful in Phase 2
Agenus’ Prophage Series G-100 (HSPPC-96), used in combination with the current standard of care in patients with newly diagnosed glioblastoma multiforme, showed significant improvement in progressio Read More >>

Tags: glioblastoma multiiforme, GBM, vaccine, clinical trial, Ageon, HSPPC-96,progression free survival

3097
Views
Additional data from Talimogene melanoma trial Additional data from Talimogene melanoma trial
Amgen’s Talimogene laherparepvec, a novel oncolytic immunotherapy shows promising results in patients with unresected stage IIIB, IIIC or IV melanoma in a Phase 3 trial. Read More >>

Tags: talimogene, melanoma, oncolytic immunotherapy, clinical trial, Amgen

5262
Views
New Alzheimer drug enters Phase 3 program New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different Read More >>

Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial

6838
Views
 Melflufen enters Phase II study in the treatment of multiple myeloma patients Melflufen enters Phase II study in the treatment of multiple myeloma patients
Melflufen, also known as J1, will be used in combination with dexamethasone for late stage, relapsing or relapsing/refractory patients with multiple myeloma. The aim of this phase study is to determi Read More >>

Tags: melflufen, J1, multiple myeloma, late stage, clinical trial

7744
Views
AstraZeneca’s olaparib to enter Phase 3 clinical program for ovarian cancer AstraZeneca’s olaparib to enter Phase 3 clinical program for ovarian cancer
AstraZeneca has initiated the enrollment of patients for a Phase III (SOLO) clinical program of its drug olaparib. The drug will be tested as a maintenance monotherapy in patients with BRCA mutated ov Read More >>

Tags: ovarian cancer, clinical trial, olaparib, AstraZeneca, SOLO, BRCA mutation, PARP inhibitor

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013